Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity

Journal of Interferon and Cytokine Research

Volumn 30, Issue 4, 2010, Pages 205-217

  Salek Ardakani, Shahram ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD27 ANTIGEN; CD30 ANTIGEN; CD30 LIGAND; CD70 ANTIGEN; DNA VACCINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HERMES ANTIGEN; HERPESVIRUS ENTRY MEDIATOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR; PROTEIN 4-1BB; PROTEIN 4-1BB LIGAND; PROTEIN LIGHT; PROTEIN OX40; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL EXPANSION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG TARGETING; EFFECTOR CELL; FOOT AND MOUTH DISEASE; HERPES SIMPLEX VIRUS 2; HUMAN; INFLUENZA; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; VACCINATION; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY; IMMUNOLOGIC MEMORY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS; VIRUS DISEASES;

EID: 77952515476     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0026     Document Type: Article

References (157)

1. Allam A, Conze DB, Giardino Torchia ML, Munitic I, Yagita H, Sowell RT, Marzo AL, Ashwell JD. 2009. The CD8+ memory T-cell state of readiness is actively maintained and reversible. Blood 114 (10):2121-2130.
2. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, Wakeham A, Mittruecker HW, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi P, Penninger JM, Mak TW. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84 (4):551-562.
3. Andreasen SO, Christensen JE, Marker O, Thomsen AR. 2000. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J Immunol 164 (7):3689-3697.
4. Arribillaga L, Sarobe P, Arina A, Gorraiz M, Borrás-Cuesta F, Ruiz J, Prieto J, Chen L, Melero I, Lasarte JJ. 2005. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Vaccine 23 (27):3493-3499.
5. Asprodites N, Zheng L, Geng D, Velasco-Gonzalez C, Sanchez-Perez L, Davila E. 2008. Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J 22 (10):3628-3637.
6. Bachmann MF, Wolint P, Schwarz K, Oxenius A. 2005. Recall proliferation potential of memory CD8+ T cells and antiviral protection. J Immunol 175 (7):4677-4685.
7. Badovinac VP, Messingham KA, Griffith TS, Harty JT. 2006. TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells. J Immunol 177 (2):999-1006.
8. Ballesteros-Tato A, León B, Lund FE, Randall TD. 2010. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8 (+) T cell responses to influenza. Nat Immunol 11 (3):216-224.
9. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison J P, Sharpe AH, Freeman GJ, Ahmed R. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (7077):682-687.
10. Bekiaris V, Gaspal F, Kim MY, Withers DR, Sweet C, Anderson G, Lane PJ. 2009. Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge. Eur J Immunol 39 (8):2120-2125.
11. Belz GT, Bedoui S, Kupresanin F, Carbone FR, Heath WR. 2007. Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells. Nat Immu nol 8 (10):1060-1066.
12. Bertram EM, Lau P, Watts TH. 2002. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J Immunol 168 (8):3777-3785.
13. Bevan MJ. 2004. Helping the CD8 (+) T-cell response. Nat Rev Immunol 4 (8):595-602.
14. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, Murali-Krishna K, Altman JD, Ahmed R. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 195 (5):657-664.
15. Boesteanu AC, Katsikis PD. 2009. Memory T cells need CD28 costimulation to remember. Semin Immunol 21 (2):69-77.
16. Borrow P, Tishon A, Lee S, Xu J, Grewal IS, Oldstone MB, Flavell RA. 1996. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 183 (5):2129-2142.
17. Borst J, Hendriks J, Xiao Y. 2005. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 17 (3):275-281.
18. Brincks EL, Katewa A, Kucaba TA, Griffith TS, Legge KL. 2008. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol 181 (7):4918-4925.
19. Bucks CM, Norton JA, Boesteanu AC, Mueller YM, Katsikis PD. 2009. Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. J Immunol 182 (11):6697-6708.
20. Bukczynski J, Wen T, Ellefsen K, Gauldie J, Watts TH. 2004. Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses. Proc Natl Acad Sci USA 101 (5):1291-1296.
21. Bukczynski J, Wen T, Watts TH. 2003. Costimulation of human CD28-T cells by 4-1BB ligand. Eur J Immunol 33 (2):446-454.
22. Butz EA, Bevan MJ. 1998. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8 (2):167-175.
23. Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. 2008. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9 (2):176-185.
24. Calarota SA, Hokey DA, Dai A, Jure-Kunkel MN, Balimane P, Weiner DB. 2008. Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule. Vaccine 26 (25):3121-3134.
25. Cottalorda A, Mercier BC, Mbitikon-Kobo FM, Arpin C, Teoh DY, McMichael A, Marvel J, Bonnefoy-Bérard N. 2009. TLR2 engagement on memory CD8 (+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag. Eur J Immunol 39 (10):2673-2681.
26. Croft M. 2003a. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 3 (8):609-620.
27. Croft M. 2003b. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev 14 (3-4): 265-273.
28. Croft M. 2005. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. Trends Immunol 26 (6):292-294.
29. Croft M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9 (4):271-285.
30. Crowe SR, Turner SJ, Miller SC, Roberts AD, Rappolo RA, Doherty PC, Ely KH, Woodland DL. 2003. Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 198 (3):399-410.
31. Cummins N, Badley A. 2009. The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr Mol Med 9 (4):495-505.
32. Davenport M P, Belz GT, Ribeiro RM. 2009. The race between infection and immunity: how do pathogens set the pace? Trends Immunol 30 (2):61-66.
33. Dawicki W, Bertram EM, Sharpe AH, Watts TH. 2004. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. J Immunol 173 (10):5944-5951.
34. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 (7109):350-354.
35. De Trez C, Ware CF. 2008. The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis. Cytokine Growth Factor Rev 19 (3-4): 277-284.
36. Dittmer U, He H, Messer RJ, Schimmer S, Olbrich AR, Ohlen C, Greenberg PD, Stromnes IM, Iwashiro M, Sakaguchi S, Evans LH, Peterson KE, Yang G, Hasenkrug KJ. 2004. Functional impairment of CD8 (+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20 (3):293-303.
37. Dittmer U, Werner T, Kraft AR. 2008. Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection. Viral Immunol 21 (4):459-467.
38. Dobbs ME, Strasser JE, Chu CF, Chalk C, Milligan GN. 2005. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin-or Fas-mediated cytolytic mechanisms. J Virol 79 (23):14546-14554.
39. Doherty PC. 1998. The numbers game for virus-specific CD8+ T cells. Science 280 (5361):227.
40. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG. 1997. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159:105-117.
41. Dolfi DV, Boesteanu AC, Petrovas C, Xia D, Butz EA, Katsikis PD. 2008. Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells. J Immunol 180 (5):2912-2921.
42. Edelmann KH, Wilson CB. 2001. Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection. J Virol 75 (2):612-621.
43. Fang M, Sigal LJ. 2005. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J Immunol 175 (10):6829-6836.
44. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. 1998. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8 (6):683-691.
45. Fuse S, Bellfy S, Yagita H, Usherwood EJ. 2007. CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J Immunol 178 (8):5227-5236.
46. Fuse S, Tsai CY, Molloy MJ, Allie SR, Zhang W, Yagita H, Usherwood EJ. 2009. Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1. J Immunol 182 (7):4244-4254.
47. Gaspal FM, Kim MY, McConnell FM, Raykundalia C, Bekiaris V, Lane PJ. 2005. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory. J Immunol 174 (7):3891-3896.
48. Grosenbach DW, Schlom J, Gritz L, Gómez Yafal A, Hodge JW. 2003. A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production. Cell Immunol 222 (1):45-57.
49. Halstead ES, Mueller YM, Altman JD, Katsikis PD. 2002. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol 3 (6):536-541.
50. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW. 2009. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 182 (6):3469-3481.
51. Haring JS, Badovinac VP, Harty JT. 2006. Inflaming the CD8+ T cell response. Immunity 25 (1):19-29.
52. Harrison JM, Bertram EM, Boyle DB, Coupar BE, Ranasinghe C, Ramshaw IA. 2006. 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine. Vaccine 24 (47-48): 6867-6874.
53. Harty JT, Badovinac VP. 2008. Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol 8 (2):107-119.
54. Harty JT, Tvinnereim AR, White DW. 2000. CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 18:275-308.
55. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 1 (5):433-440.
56. Hendriks J, Xiao Y, Borst J. 2003. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 198 (9):1369-1380.
57. Hendriks J, Xiao Y, Rossen JW, van der Sluijs KF, Sugamura K, Ishii N, Borst J. 2005. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J Immunol 175 (3):1665-1676.
58. Hikono H, Kohlmeier JE, Ely KH, Scott I, Roberts AD, Blackman MA, Woodland DL. 2006. T-cell memory and recall responses to respiratory virus infections. Immunol Rev 211:119-132.
59. Hikono H, Kohlmeier JE, Takamura S, Wittmer ST, Roberts AD, Woodland DL. 2007. Activation phenotype, rather than centralor effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med 204 (7):1625-1636.
60. Humphreys IR, Loewendorf A, de Trez C, Schneider K, Benedict CA, Munks MW, Ware CF, Croft M. 2007. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism. J Immunol 179 (4):2195-2202.
61. Humphreys IR, Walzl G, Edwards L, Rae A, Hill S, Hussell T. 2003. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med 198 (8):1237-1242.
62. Hussell T, Snelgrove R, Humphreys IR, Williams AE. 2004. Co-stimulation: novel methods for preventing viral-induced lung inflammation. Trends Mol Med 10 (8):379-386.
63. Ishikawa E, Nakazawa M, Yoshinari M, Minami M. 2005. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice. J Virol 79 (12):7658-7663.
64. Ishikawa T, Yamada H, Oyamada A, Goshima F, Nishiyama Y, Yoshikai Y. 2009. Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice. J Virol 83 (22):11777-11783.
65. Jameson SC, Masopust D. 2009. Diversity in T cell memory: an embarrassment of riches. Immunity 31 (6):859-871.
66. Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP. 2005. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 (7029):88-93.
67. Kaech SM, Wherry EJ. 2007. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27 (3):393-405.
68. Khanolkar A, Badovinac VP, Harty JT. 2007. CD8 T cell memory development: CD4 T cell help is appreciated. Immunol Res 39 (1-3): 94-104.
69. Kim HS, Kim-Schulze S, Kim DW, Kaufman HL. 2009. Host lymphodepletion enhances the therapeutic activity of an oncolytic vaccinia virus expressing 4-1BB ligand. Cancer Res 69 (21):8516-8525.
70. Kim MY, Gaspal FM, Wiggett HE, McConnell FM, Gulbranson-Judge A, Raykundalia C, Walker LS, Goodall MD, Lane PJ. 2003. CD4 (+) CD3 (-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 18 (5):643-654.
71. Kohlmeier JE, Woodland DL. 2009. Immunity to respiratory viruses. Annu Rev Immunol 27:61-82.
72. Kopf M, Ruedl C, Schmitz N, Gallimore A, Lefrang K, Ecabert B, Odermatt B, Bachmann MF. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity 11 (6):699-708.
73. Kumaraguru U, Davis IA, Deshpande S, Tevethia SS, Rouse BT. 2001. Lymphotoxin alpha-/-mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J Immunol 166 (2):1066-1074.
74. La S, Kim E, Kwon B. 2005. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Exp Mol Med 37 (3):193-198.
75. Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, Borrow P, Tough DF. 2003. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4 (10):10 09-1015.
76. Lee BJ, Santee S, Von Gesjen S, Ware CF, Sarawar SR. 2000. Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis. J Virol 74 (6):2786-2792.
77. Lee SJ, Rossi RJ, Lee SK, Croft M, Kwon BS, Mittler RS, Vella AT. 2007. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent. J Immunol 179 (4):2203-2214.
78. Legge KL, Braciale TJ. 2005. Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity 23 (6):649-659.
79. Li Q, Skinner PJ, Ha SJ, Duan L, Mattila TL, Hage A, White C, Barber DL, O'Mara L, Southern PJ, Reilly CS, Carlis JV, Miller CJ, Ahmed R, Haase AT. 2009. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323 (5922):1726-1729.
80. Lin GH, Sedgmen BJ, Moraes TJ, Snell LM, Topham DJ, Watts TH. 2009. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease. J Immunol 182 (2):934-947.
81. Lowin B, Hahne M, Mattmann C, Tschopp J. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370 (6491):650-652.
82. Lund FE, Partida-Sánchez S, Lee BO, Kusser KL, Hartson L, Hogan RJ, Woodland DL, Randall TD. 2002. Lymphotoxin-alphadeficient mice make delayed, but effective, T and B cell responses to influenza. J Immunol 169 (9):5236-5243.
83. Ma DY, Clark EA. 2009. The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 21 (5):265-272.
84. Matter MS, Claus C, Ochsenbein AF. 2008. CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression. Eur J Immunol 38 (7):1847-1856.
85. Matter M, Mumprecht S, Pinschewer DD, Pavelic V, Yagita H, Krautwald S, Borst J, Ochsenbein AF. 2005. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL. Eur J Immunol 35 (11):3229-3239.
86. McCarron M, Reen DJ. 2009. Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation. J Immunol 182 (1):55-62.
87. McGill J, Legge KL. 2009. Cutting edge: contribution of lung-resident T cell proliferation to the overall magnitude of the antigen-specific CD8 T cell response in the lungs following murine influenza virus infection. J Immunol 183 (7):4177-4181.
88. McGill J, Van Rooijen N, Legge KL. 2008. Protective influenzaspecific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med 205 (7):1635-1646.
89. Mercier BC, Cottalorda A, Coupet CA, Marvel J, Bonnefoy-Bérard N. 2009. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal. J Immunol 182 (4):1860-1867.
90. Milligan GN, Dudley-McClain KL, Young CG, Chu CF. 2004. T-cellmediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice. J Reprod Immunol 61 (2):115-127.
91. Mueller YM, De Rosa SC, Hutton JA, Witek J, Roederer M, Altman JD, Katsikis PD. 2001. Increased CD95/Fas-induced apoptosis of HIV-specific CD8 (+) T cells. Immunity 15 (6):871-882.
92. Munks MW, Mourich DV, Mittler RS, Weinberg AD, Hill AB. 2004. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. Immunology 112 (4):559-566.
93. Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac A, Ahmed R. 1998. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. Adv Exp Med Biol 452:123-142.
94. Nishimura H, Yajima T, Muta H, Podack ER, Tani K, Yoshikai Y. 2005. A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells. J Immunol 175 (7):4627-4634.
95. Nolte MA, van Olffen RW, van Gisbergen K P, van Lier RA. 2009. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 229 (1):216-231.
96. Peperzak V, Xiao Y, Veraar EA, Borst J. 2010. CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest 120 (1):168-178.
97. Petrovas C, Mueller YM, Katsikis PD. 2004. HIV-specific CD8+ T cells: serial killers condemned to die? Curr HIV Res 2 (2):153-162.
98. Pippig SD, Peña-Rossi C, Long J, Godfrey WR, Fowell DJ, Reiner SL, Birkeland ML, Locksley RM, Barclay AN, Killeen N. 1999. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J Immunol 163 (12):6520-6529.
99. Podack ER, Strbo N, Sotosec V, Muta H. 2002. CD30-governor of memory T cells? Ann N Y Acad Sci 975:101-113.
100. Poonia B, Pauza CD, Salvato MS. 2009a. Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology 6:91.
101. Poonia B, Salvato MS, Yagita H, Maeda T, Okumura K, Pauza CD. 2009b. Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus. Blood 114 (6):1196-1204.
102. Prlic M, Hernandez-Hoyos G, Bevan MJ. 2006. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J Exp Med 203 (9):2135-2143.
103. Pulle G, Vidric M, Watts TH. 2006. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J Immunol 176 (5):2739-2748.
104. Quaranta MG, Mattioli B, Giordani L, Viora M. 2004. HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion. FASEB J 18 (12):1459-1461.
105. Reading PC, Smith GL. 2003. A kinetic analysis of immu ne mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 84 (Pt 8):1973-1983.
106. Roberts AD, Ely KH, Woodland DL. 2005. Differential contributions of central and effector memory T cells to recall responses. J Exp Med 202 (1):123-133.
107. Roberts AD, Woodland DL. 2004. Cutting edge: effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J Immunol 172 (11):6533-6537.
108. Roe MF, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O'Donnell DR. 2004. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 137 (1):139-145.
109. Sabbagh L, Snell LM, Watts TH. 2007. TNF family ligands define niches for T cell memory. Trends Immunol 28 (8):333-339.
110. Salek-Ardakani S, Arens R, Flynn R, Sette A, Schoenberger SP, Croft M. 2009. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J Immunol 182 (5):2909-2918.
111. Salek-Ardakani S, Croft M. 2006. Regulation of CD4 T cell memory by OX40 (CD134). Vaccine 24 (7):872-883.
112. Salek-Ardakani S, Moutaftsi M, Crotty S, Sette A, Croft M. 2008. OX40 drives protective vaccinia virus-specific CD8 T cells. J Immunol 181 (11):7969-7976.
113. Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745-763.
114. Schildknecht A, Miescher I, Yagita H, van den Broek M. 2007. Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells. Eur J Immunol 37 (3):716-728.
115. Schneider K, Potter KG, Ware CF. 2004. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 202:49-66.
116. Seder RA, Darrah PA, Roederer M. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8 (4):247-258.
117. Sedgmen BJ, Dawicki W, Gommerman JL, Pfeffer K, Watts TH. 2006. LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice. Int Immunol 18 (5):797-806.
118. Sedý JR, Spear PG, Ware CF. 2008. Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol 8 (11):861-873.
119. Seedhom MO, Jellison ER, Daniels KA, Welsh RM. 2009. High frequencies of virus-specific CD8+ T-cell precursors. J Virol 83 (24):12907-12916.
120. Seo SK, Park HY, Choi JH, Kim WY, Kim YH, Jung HW, Kwon B, Lee HW, Kwon BS. 2003. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J Immunol 171 (2):576-583.
121. Serghides L, Bukczynski J, Wen T, Wang C, Routy J P, Boulassel MR, Sekaly R P, Ostrowski M, Bernard NF, Watts TH. 2005. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL. J Immunol 175 (10):6368-6377.
122. Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. 1998. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 10 (5):581-587.
123. Shrestha B, Diamond MS. 2007. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J Virol 81 (21):11749-11757.
124. Sitati E, McCandless EE, Klein RS, Diamond MS. 2007. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. J Virol 81 (18):9801-9811.
125. Sousa AE, Chaves AF, Doroana M, Antunes F, Victorino RM. 1999. Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin Exp Immunol 116 (2):307-315.
126. Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF, Kornbluth RS. 2006. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol 80 (4):1762-1772.
127. Suresh M, Lanier G, Large MK, Whitmire JK, Altman JD, Ruddle NH, Ahmed R. 2002. Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J Virol 76 (8):3943-3951.
128. Surh CD, Sprent J. 2008. Homeostasis of naive and memory T cells. Immunity 29 (6):848-862.
129. Suvas S, Kim B, Sarangi PP, Tone M, Waldmann H, Rouse BT. 2005. In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. J Virol 79 (18):11935-11942.
130. Takasawa N, Ishii N, Higashimura N, Murata K, Tanaka Y, Nakamura M, Sasaki T, Sugamura K. 2001. Expression of gp34 (OX40 ligand) and OX40 on human T cell clones. Jpn J Cancer Res 92 (4):377-382.
131. Tan JT, Whitmire JK, Ahmed R, Pearson TC, Larsen CP. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol 163 (9):4859-4868.
132. Tesselaar K, Gravestein LA, van Schijndel GM, Borst J, van Lier RA. 1997. Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J Immunol 159 (10):4959-4965.
133. Tesselaar K, Xiao Y, Arens R, van Schijndel GM, Schuurhuis DH, Mebius RE, Borst J, van Lier RA. 2003. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol 170 (1):33-40.
134. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K. 2006. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 177 (3):1746-1754.
135. Thomsen AR, Nansen A, Christensen JP, Andreasen SO, Marker O. 1998. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J Immunol 161 (9):4583-4590.
136. Van Deusen KE, Rajapakse R, Bullock TN. 2010. CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responses. J Leukoc Biol 87 (3):477-485.
137. van Stipdonk MJ, Hardenberg G, Bijker MS, Lemmens EE, Droin NM, Green DR, Schoenberger SP. 2003. Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol 4 (4):361-365.
138. van Stipdonk MJ, Lemmens EE, Schoenberger SP. 2001. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2 (5):423-429.
139. Waller EC, McKinney N, Hicks R, Carmichael AJ, Sissons JG, Wills MR. 2007. Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28 (-) CD45RA (HI)) CD8 (+) T cells. Blood 110 (13):4360-4366.
140. Wang C, Wen T, Routy JP, Bernard NF, Sekaly RP, Watts TH. 2007. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells. J Immunol 179 (12):8252-8263.
141. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10 (12):1366-1373.
142. Ware CF. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23:787-819.
143. Ware CF. 2008. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 223:186-201.
144. Watts TH. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23:23-68.
145. Wherry EJ, Teichgräber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4 (3):225-234.
146. Whitmire JK, Flavell RA, Grewal IS, Larsen CP, Pearson TC, Ahmed R. 1999. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol 163 (6):3194-3201.
147. Whitmire JK, Slifka MK, Grewal IS, Flavell RA, Ahmed R. 1996. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J Virol 70 (12):8375-8381.
148. Williams MA, Bevan MJ. 2007. Effector and memory CTL differentiation. Annu Rev Immunol 25:171-192.
149. Wissinger EL, Saldana J, Didierlaurent A, Hussell T. 2008. Manipulation of acute inflammatory lung disease. Mucosal Immunol 1 (4):265-278.
150. Wolfe T, Asseman C, Hughes A, Matsue H, Takashima A, von Herrath MG. 2002. Reduction of antiviral CD8 lymphocytes in vivo with dendritic cells expressing Fas ligand-increased survival of viral (lymphocytic choriomeningitis virus) central nervous system infection. J Immunol 169 (9):4867-4872.
151. Wong P, Pamer EG. 2003. CD8 T cell responses to infectious pathogens. Annu Rev Immunol 21:29-70.
152. Woodland DL, Dutton RW. 2003. Heterogeneity of CD4 (+) and CD8 (+) T cells. Curr Opin Immunol 15 (3):336-342.
153. Woodland DL, Kohlmeier JE. 2009. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol 9 (3):153-161.
154. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. 2009. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182 (5):2786-2794.
155. Xiao C, Rajput ZI, Hu S. 2007. Improvement of a commercial footand-mouth disease vaccine by supplement of Quil A. Vaccine 25 (25):4795-4800.
156. Yewdell JW, Bennink JR. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17:51-88.
157. Yu Q, Yue FY, Gu XX, Schwartz H, Kovacs CM, Ostrowski MA. 2006. OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition. J Immunol 176 (4):2486-2495.